A new perspective on modic type 1 changes in degenerative disc disease: a systematic evidence-based educational...

Modic type 1 changes (MC1) are magnetic resonance imaging (MRI)-defined vertebral endplate and subchondral bone marrow alterations frequently observed in degenerative disc disease (DDD). Compared with other Modic subtypes, MC1 has been more frequently associated with chronic low back pain and inflammatory features; however, its causal, prognostic, and treatment-predictive significance remains uncertain. The purpose of this systematic evidence-based educational review is to critically synthesize the current MC1-specific literature across clinically distinct domains, including its association with low back pain, prognostic significance and natural history, MRI diagnostic discrimination, and treatment-response evidence, while considering the hierarchy and methodological quality of the available evidence.

A PRISMA-compliant systematic search of PubMed and Scopus was conducted to identify radiological studies evaluating Modic type 1 changes on MRI. Studies were included if MC1 was clearly defined according to the original Modic classification and if diagnostic, clinical, longitudinal, or therapeutic outcomes were reported. Twenty studies met the eligibility criteria; however, one article was excluded due to unavailable full text, resulting in nineteen studies included in the qualitative synthesis. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‑Analyses (PRISMA 2020) guidelines. The review protocol was registered in PROSPERO (CRD420261369453). A formal risk‑of‑bias assessment was performed: the methodological quality of the included studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools, selecting the checklist appropriate to each study design. The risk of bias of the review process was additionally assessed using the Risk of Bias in Systematic Reviews (ROBIS) tool.

Nineteen studies were included in the qualitative synthesis. The available evidence suggests that MC1 may represent a biologically active MRI phenotype within the spectrum of degenerative disc-endplate disease, characterized by fibrovascular marrow replacement, inflammatory signaling, endplate disruption, and nociceptive nerve ingrowth. MC1 was frequently associated with low back pain, particularly in patients with disc pathology or persistent lesions; however, the strength of this association varied across studies and causality could not be established. Longitudinal data indicate that MC1 is a dynamic finding that may develop, persist, regress, or interconvert with other Modic subtypes over time. Clinical and histopathological studies support an inflammatory and nociceptive phenotype, while diagnostic studies emphasize the need to distinguish MC1 from inflammatory and infectious mimics. Therapeutic evidence remains limited: short-term responses to anti-inflammatory or mechanical unloading strategies have been reported, basivertebral nerve ablation appears promising in selected patients, and antibiotic therapy is not supported for routine use because of conflicting randomized evidence.

MC1 should be interpreted as a potentially meaningful but non-specific imaging biomarker of active disc-endplate degeneration and possible vertebrogenic pain, rather than as an isolated or universally causal pain generator. Its clinical relevance depends on the broader context, including coexisting degenerative abnormalities, endplate morphology, inflammatory clinical features, psychosocial contributors, and possible imaging selection bias. The review process showed low concern for bias according to ROBIS; however, the certainty of evidence is limited by the heterogeneous methodological quality of the included studies, variable MRI protocols, small or selected cohorts, incomplete confounder adjustment, and limited long-term comparative data. Further prospective, adequately powered, and methodologically rigorous studies are needed to standardize MRI definitions, clarify the natural history and diagnostic specificity of MC1, and determine its prognostic and treatment-guiding value in patients with low back pain.